Smruthi Organics Ltd

Smruthi Organics Ltd has received an inspection report from the Brazilian Health Regulatory Agency (ANVISA) for its Unit II in Solapur, Maharashtra. The inspection, conducted from June 7-11, 2026, classified the facility as "Complies with Good Manufacturing Practices with Corrective Action." The report indicates conditions for certification for the inspected active pharmaceutical ingredient. This is a significant step towards obtaining the final GMP certificate, although it has not yet been received. Further disclosures will be made upon receipt of the certificate.

Smruthi Organics Ltd has received approval from the Central Government, Ministry of Corporate Affairs, for the appointment of Ms. Smruthi Purushotham Eaga as a Whole-time Director. This appointment is for a period of three years, commencing from June 1, 2026, to May 31, 2029. The approval was granted following the company's application filed on August 26, 2026, and is subject to certain conditions, including an undertaking from Ms. Eaga regarding potential conflicts of interest in selling agencies. The company has been informed of the approval via a letter dated October 7, 2026.

Smruthi Organics Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its Un-Audited Financial Results for the second quarter ended September 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The company will inform the date of the Board of Directors' meeting to approve these results in due course. Designated persons are prohibited from trading in the company's securities during this period.

Smruthi Organics Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors approved the results in a meeting held on August 10, 2026. The company's financial performance for the quarter will be available on its website. The results were reviewed by the Audit Committee and approved by the Board, adhering to Indian Accounting Standards (Ind AS).

Smruthi Organics Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors approved the results in a meeting held on August 10, 2026. The company will also make these results available on its website. The filing includes a limited review report from the statutory auditors.

Smruthi Organics Ltd has announced that its Board of Directors will convene on August 10, 2026. The primary agenda item is to consider and approve the un-audited financial results for the first quarter ended June 30, 2026, prepared under Indian Accounting Standards (Ind AS). Concurrently, the company confirmed that the trading window, which closed on July 1, 2026, will remain shut until 48 hours after the declaration of these financial results.

Smruthi Organics Ltd has announced its 37th Annual General Meeting (AGM) to be held on Monday, August 10, 2026, at 02:30 p.m. IST. The meeting will be conducted exclusively through Video Conferencing or Other Audio-Visual Means, adhering to recent circulars from the Ministry of Corporate Affairs and SEBI. The AGM will cover the adoption of audited financial statements for FY 2025-2026, the declaration of a dividend of ₹1.50 per share, the re-appointment of a director, ratification of the Cost Auditor's remuneration, and a change in designation and remuneration for Ms. Smruthi Eaga. The Annual Report and AGM notice are being dispatched electronically to shareholders.

Smruthi Organics Limited has announced its 37th Annual General Meeting (AGM) to be held on Monday, August 10, 2026, at 02:30 p.m. IST, conducted entirely through Video Conferencing or Other Audio-Visual Means, in compliance with Ministry of Corporate Affairs and SEBI circulars. The Annual Report for FY 2025-2026, along with the AGM notice, has been dispatched electronically to shareholders. Key agenda items include the adoption of audited financial statements, declaration of a dividend of ₹1.50 per share, re-appointment of a director, ratification of the Cost Auditor's remuneration, and a change in designation and remuneration for Ms. Smruthi Eaga.

Smruthi Organics Ltd has announced the closure of its trading window from July 1, 2026, until 48 hours after the declaration of its Un-Audited Financial Results for the first quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The company has requested all designated persons and insiders to refrain from trading in the company's securities during this period. The date for the Board of Directors' meeting to approve these financial results will be communicated separately.

Smruthi Organics Ltd has fixed Friday, July 31, 2026, as the record date for determining the eligibility of members entitled to receive a dividend of ₹1.50 per equity share of ₹10 each (15%) for the financial year 2025-26, if declared at the 37th Annual General Meeting of the Company. This follows the board's recommendation of the dividend as announced on May 13, 2026.